Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock

Figures

• 

  Figure 1. One-year all-cause mortality in propensity-matched cardiogenic shock and non-cardiogenic shock groups.

• 

  Figure 2. Thirty-day landmark analysis of propensity-matched cardiogenic shock and non-cardiogenic shock groups through 1 year CS.

• 

  Figure 3. One-year all-cause mortality for pre-specified subgroups in the cardiogenic shock group. (A) ≥Moderate mitral regurgitation vs. ≤ mild/trace/none mitral regurgitation. (B) Left ventricular ejection fraction <20% vs. 20%–40% vs. > 40%. (C) Native cases vs. valve-in-valve. (D) Pre-procedure inotropes only, vs. mechanical circulatory support only vs. mechanical circulatory support and inotropes vs. coding of CS on TVT-R form/cardiac arrest.

• 

  Figure 4. Multivariate predictors of all-cause mortality in patients with cardiogenic shock. (A) Multivariate predictors of all-cause mortality at 30 days in patients with cardiogenic shock. (B) Multivariate predictors of all-cause mortality at 1 year in patients with cardiogenic shock. AV, aortic valve; BL, baseline; HGB, haemoglobin; VIV, valve-in-valve; ICD, implantable cardioverter-defibrillator; MI, myocardial infarction.